生活立场医疗

最新新闻

• 评级变动
  J.P. Morgan Maintains LifeStance Health(LFST.US) With Hold Rating, Raises Target Price to $13
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  KeyBanc Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  Jefferies Initiates LifeStance Health(LFST.US) With Buy Rating, Announces Target Price $14
  \u5e02\u573a\u8d44\u8baf · 2026/7/17
• 评级变动
  Barclays Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• Jefferies Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• 评级变动
  William Blair Maintains LifeStance Health(LFST.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 公司公告
  LifeStance Health: LifeStance Health Group, Inc. - Flex Position Consolidations Option Symbol: 1LFST
  OCC · 2024/10/22
• 评级变动
  Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/8/19
• 评级变动
  CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• Barclays Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  A Quick Look at Today's Ratings for LifeStance Health(LFST.US), With a Forecast Between $13 to $16
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Barclays Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  J.P. Morgan Sticks to Its Hold Rating for Lifestance Health Group (LFST)
  TipRanks · 2026/8/14
• KeyBanc Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/8/12

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。